fig2

The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers

Figure 2. The OVCAR8 and NCI/ADR-RES cell line pair confirm P-gp substrates. (A) Trypsinized OVCAR8 or NCI/ADR-RES cells were incubated with 2% bovine serum albumin/PBS containing phycoerythrin-labeled UIC-2 antibody to isotype control antibody for 20 min, after which cells were washed in PBS and read on a flow cytometer. Control cells (no antibody) are denoted by red curves, isotype control staining is denoted by blue curves, and P-gp staining is denoted by orange curves (ABCG2 top row, P-gp bottom row). Results from one of three independent experiments are shown; (B) Three-day cytotoxicity assays were performed on OVCAR8 and NCI/ADR-RES cells with imidazole ketone erastin, piperazine erastin, FIN56 or erastin. Where noted, the P-gp inhibitor valspodar was added at a concentration of 10 µM. Results from one of three independent experiments are shown and results are summarized in Supplementary Table 1.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/